The first widely influential system was devised in 1926 by Bailey and Cushing, who divided these neoplasm into three entities according to their histological similarity to normal embryonic glia 4 .
In 1949, Kernohan et al, proposed a four tiered system based on the degree of anaplasia 5 .
For many years the Kernohan system was the mainstay of pathologic classification of glial tumor and it remains influential today because of its widespread use in the training of pathologists and neuro-pathologists 6, 7 .
In 1950, Ringertz proposed a three tiered system that was later popularized by Burger et al and used in many cooperative brain tumor clinical trials 8 .
The most recently introduced grading system is that of the revised World Health Organization 9 .
Pilocytic astrocytomas presumably arise from a class of astrocytes that is inconspicuous in normal brain but may become prominent in reactive gliosis and neoplasia 10 .
Incidence all gliomas 5% to 10% of but account for nearly one third of pediatric neoplasm 11 .
Pilocytic astrocytomas typically are tumors of children and young adults, most tumors in the cerebellum become symptomatic during the first two decades of life 12 .
Pilocytic astrocytomas are characteristically located around the third and fourth ventricles. Less common locations include the brainstem and basal ganglia 13 . The frontal lobe are the most common location of hemispheric pilocytic astrocytoma 14 .
Zulch 11 showed that average age of intracranial astrocytoma was 36.15 years when it was 31.51 years in Dastur's 15 series. According to the study of Mc Kernan and Thoma 16 mean age for low grade astrocytoma was 37.4 years.
Cerebral hemispheres specially frontal (40%), temporal (25%), and parietal (25%) lobes 16 . Others (10%) include thalamus, midbrain and pons.
Anaplastic Astrocytomas are in Kernohan's grade three and in WHO grade III.
Age incidence of glioblastoma multiforme is usually in patients over 50 years and are rare in patients under 30. Glioblastoma can occasionally be found at any age. 2 According to Burger P. C. 17 median age 50 to 60 years.
Incidence of gliomas are 45% to 50%. 18 Any region of CNS possible; cerebral hemispheres predominate (40% frontal, 25% temporal, 25% parietal) 19 .
Symptoms of raised intracranial pressure more common than with lower grade tumors. 20 Mental status changes and motor deficit also common. Seizure at presentation is approximately 32% 21 .
Methodology:
This is a cross sectional study which was carried out at the Department of Neurosurgery, Bangabandhu Sheikh Mujib Medical University (BSMMU). The study was carried out from July 2003 to June 2005. 44 cases were studied. Inclusion criteria are patients with intracranial astrocytomas admitted in dept. of neurosurgery, BSMMU. Exclusion Criteria are patients of intracranial astrocytomas who denied to be included in the study.
A questionnaire was prepared considering the variables such as age and sex of the patient, clinical features, site of tumor, image findings, per operative findings and histopathological reports. Histopathological report of the tumor was collected and then recorded.
Data were processed through computer software SPSS version 11. Statistical calculations were performed by SPSS software. Chi-square test was applied to test for significance and conclusion was drawn at 1% level of significance.
Results:
The study was done on 44 patients of intracranial astrocytomas, all patients underwent craniotomy or burr hole biopsy to prove the histopathological diagnosis. Table III shows the consciousness level of the patients. 38 patients (86.3%) were found conscious oriented. 5 cases (11.4%) were confused (GCS, 13-14) and 1 patient had GCS 7-12. Regarding the function of Trigeminal, Glossopharyngeal, Vagus, Accessory and Hypoglossal nerves all the patients were found to be normal. So there is association between age group and histopathological subtype in case of intracranial astrocytoma patients.
Discussion
Age incidence of intracranial astrocytomas is a very important variable which varies from study to study. Age incidence of astrocytoma was 31.51 years in Dastur's (1969) series 22 .
According to the study of McKeran and Thomas mean age for low grade astrocytomas was 37.4 years, for anaplastic astrocytomas 45.8 years and for glioblastoma multiforme 52 year 23 .
According to Youman's study, pilocytic astrocytomas occurred in childhood, low grade astrocytomas are non contrast enhancing area usually present in fourth decades 4 .
According to Osborn 2 pilocytic astrocytomas typically are tumors of children and young adult.
In our study we found that mean age of low grade astrocytomas (WHO grade I) was 30.7 years. This is almost similar to other international studies. Mean age of anaplastic astrocytoma (grade III) was 36.4 years, which is little earlier than the other studies. In case of glioblastoma multiforme mean age was 46.5 years, which is near to the study of McKeran and Thomas 24 . Mean age of pilocytic astrocytomas (grade I) was 23.7 years, which is little older than the international studies where it was during the first two decades of life.
In our study mean age of all intracranial astrocytoma patients was 33.1 yaers which is very close to the result of Dastur's (31.51 years) study.
Sex incidents of intracranial astrocytomas also varies from study to study. In our study, we found a Relationship between age groups and histopathological subtypes: In this study highest number of cases were found in less than 20 years group and it was 15 cases. The youngest patient was 1 year old and the oldest patient was 65 years old showing that no age group is exempted for intracranial astrocytomas.
In our study the percentage of glioblastoma multiforme was 22.7% which is surprisingly low than the international studies where it was the common of all gliomas. Probably poor prognosis and rapid deterioration may be one of the important cause of not reaching of such types of patients in hospital in proper time. Headache or seizure is sometimes the early or only symptom for intracranial astrocytoma patients which are ignored by a lot of patients or attendant vary frequently. Investigation of intracranial astrocytoma patients (CT/MRI) are very expensive which were also avoided by the patients or their relatives very frequently which is another important cause of not reaching hospital in time.
Analysis of clinical features revealed that presenting symptoms were headache, vomiting, convulsion, altered consciousness, blurring of vision, limb weakness and cranial nerve dysfunction. Most of the symptoms were related to raised intracranial pressure and mass effect by the tumor.
Jackle et al. reported seizure in 65-70% of low grade glioma and 30-50% in glioblastoma patients 24 .
Tandon showed apathy, change in personality, impaired memory attention concentration and inappropriate social behavior are the common feature of fronto temporal astrocytomas 25 .
In this study we observed 81.8% patients presented with headache, 59% of the patients had history of seizure, 47.7% of them had visual disturbance and limb weakness was present in 45.5% of the patients. So, the presenting symptoms of this study is almost similar to other studies.
McKeran and Thomas reported 50-70% patients with papilloedema. 16 In our study 38.6% of the patients had papilloedema which is very near to that study.
This study showed 77.3% of the patients with normal facial nerve function and 22.7% with upper motor type deficit.
In this study 79.6% patients were found with normal speech, 13.6% with dysphasia and 6.8% with dysarthria. Early dysphasia is often overlooked or confused with memory impairment 25 .
In imaging (CT / MRI) study 36.4% patients had complex enhancement, 18.2% had enhancement with necrosis and rest 45.4% without enhancement. Piepmier 26 had shown in a large series that those patients whose tumors enhance on imaging had a poorer prognosis than those whose lesion did not enhance after administration of I/V contrast. 
Conclusion:
This study has shown that there is significant relationship between age groups and histopathological subtypes in case of intracranial astrocytoma patients.
